These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 12228260)

  • 21. Serum immunoglobulin G response to candidate vaccine antigens during experimental human pneumococcal colonization.
    McCool TL; Cate TR; Tuomanen EI; Adrian P; Mitchell TJ; Weiser JN
    Infect Immun; 2003 Oct; 71(10):5724-32. PubMed ID: 14500493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of systemic and mucosal immune response and decrease in Streptococcus pneumoniae colonization by nasal inoculation of mice with recombinant lactic acid bacteria expressing pneumococcal surface antigen A.
    Oliveira ML; Arêas AP; Campos IB; Monedero V; Perez-Martínez G; Miyaji EN; Leite LC; Aires KA; Lee Ho P
    Microbes Infect; 2006 Apr; 8(4):1016-24. PubMed ID: 16549380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pneumococcal vaccine combination with two proteins containing PspA families 1 and 2 can potentially protect against a wide range of Streptococcus pneumoniae strains.
    Yu J; Chen X; Li B; Gu T; Meng X; Kong W; Wu Y
    Immunol Res; 2018 Aug; 66(4):528-536. PubMed ID: 30128745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunogenic protein contaminants in pneumococcal vaccines.
    Yu J; Briles DE; Englund JA; Hollingshead SK; Glezen WP; Nahm MH
    J Infect Dis; 2003 Mar; 187(6):1019-23. PubMed ID: 12660950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression, purification, and characterization of pneumococcal PsaA-PspA fusion protein.
    Guo X; Sun Q; Xi H; Zhang Y; Guo M; Zhang C; Zhu S; Gu T; Kong W; Wu Y
    Protein Expr Purif; 2021 Feb; 178():105782. PubMed ID: 33122039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of four adjuvants revealed the strongest protection against lethal pneumococcal challenge following immunization with PsaA-PspA fusion protein and AS02 as adjuvant.
    Chen X; Li B; Yu J; Zhang Y; Mo Z; Gu T; Kong W; Zhang Y; Wu Y
    Med Microbiol Immunol; 2019 Apr; 208(2):215-226. PubMed ID: 30707297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies.
    Lue C; Tarkowski A; Mestecky J
    J Immunol; 1988 Jun; 140(11):3793-800. PubMed ID: 3372993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The potential for using protein vaccines to protect against otitis media caused by Streptococcus pneumoniae.
    Briles DE; Hollingshead SK; Nabors GS; Paton JC; Brooks-Walter A
    Vaccine; 2000 Dec; 19 Suppl 1():S87-95. PubMed ID: 11163470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunoprotective effect of combined pneumococcal endopeptidase O and pneumococcal surface adhesin A vaccines against Streptococcus pneumoniae infection].
    Zhang J; Cui YL; Jiang YM
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 May; 19(5):583-589. PubMed ID: 28506354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.
    Nguyen CT; Kim SY; Kim MS; Lee SE; Rhee JH
    Vaccine; 2011 Aug; 29(34):5731-9. PubMed ID: 21696869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mucosal vaccination with a multicomponent adenovirus-vectored vaccine protects against Streptococcus pneumoniae infection in the lung.
    Arévalo MT; Xu Q; Paton JC; Hollingshead SK; Pichichero ME; Briles DE; Girgis N; Zeng M
    FEMS Immunol Med Microbiol; 2009 Apr; 55(3):346-51. PubMed ID: 19291171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mucosal immunization with PsaA protein, using chitosan as a delivery system, increases protection against acute otitis media and invasive infection by Streptococcus pneumoniae.
    Xu JH; Dai WJ; Chen B; Fan XY
    Scand J Immunol; 2015 Mar; 81(3):177-85. PubMed ID: 25565478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of natural antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A and pneumolysin in Filipino pregnant women and their infants in relation to pneumococcal carriage.
    Holmlund E; Quiambao B; Ollgren J; Nohynek H; Käyhty H
    Vaccine; 2006 Jan; 24(1):57-65. PubMed ID: 16115703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The potential to use PspA and other pneumococcal proteins to elicit protection against pneumococcal infection.
    Briles DE; Hollingshead S; Brooks-Walter A; Nabors GS; Ferguson L; Schilling M; Gravenstein S; Braun P; King J; Swift A
    Vaccine; 2000 Feb; 18(16):1707-11. PubMed ID: 10689153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of higher antibody levels to pneumococcal proteins with protection from pneumococcal acute otitis media but not protection from nasopharyngeal colonization in young children.
    Xu Q; Casey JR; Almudevar A; Pichichero ME
    Clin Microbiol Infect; 2017 Jul; 23(7):487.e1-487.e6. PubMed ID: 28143785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Otitis-prone Children Have Immunologic Deficiencies in Naturally Acquired Nasopharyngeal Mucosal Antibody Response after Streptococcus pneumoniae Colonization.
    Xu Q; Casey JR; Newman E; Pichichero ME
    Pediatr Infect Dis J; 2016 Jan; 35(1):54-60. PubMed ID: 26448450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies to pneumococcal surface protein A families 1 and 2 in serum and saliva of children and the risk of pneumococcal acute otitis media.
    Simell B; Melin M; Lahdenkari M; Briles DE; Hollingshead SK; Kilpi TM; Kayhty H
    J Infect Dis; 2007 Nov; 196(10):1528-36. PubMed ID: 18008233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune responses to specific antigens of Streptococcus pneumoniae and Moraxella catarrhalis in the respiratory tract.
    Samukawa T; Yamanaka N; Hollingshead S; Klingman K; Faden H
    Infect Immun; 2000 Mar; 68(3):1569-73. PubMed ID: 10678976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased IgG but normal IgA anti-pneumococcal protein antibodies in lung of HIV-infected adults.
    Collins AM; Batrawy SE; Gordon SB; Ferreira DM
    Vaccine; 2013 Aug; 31(35):3469-72. PubMed ID: 23664995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of antibodies to PspA and PsaA in adults over 50 years of age with invasive pneumococcal disease.
    Baril L; Briles DE; Crozier P; King J; Punar M; Hollingshead SK; McCormick JB
    Vaccine; 2004 Dec; 23(6):789-93. PubMed ID: 15542203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.